Showing results 1 to 20 of 38
next >
| Issue Date | Title | Author(s) |
| 2023-10-12 | PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Travis, G; McGowan, EM; Simpson, AM; Marsh, DJ; Nassif, NT |
| 2023-09-06 | Evaluating High and Low Heart Rate Variability Response and Neurocognitive Performance in Workers: An Exploratory Study. | Eslami, A; Nassif, NT; Lal, S |
| 2022-07-08 | Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment. | Mahoney, ALG; Nassif, NT; O'Brien, BA; Simpson, AM |
| 2022 | Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform. | Chen, H; Haddadi, N; Zhu, X; Hatoum, D; Chen, S; Nassif, NT; Lin, Y; McGowan, EM |
| 2021-12-17 | Manipulating cellular microRNAs and analyzing high-dimensional gene expression data using machine learning workflows. | Saini, V; Joglekar, MV; Wong, WKM; Jiang, G; Nassif, NT; Simpson, AM; Ma, RCW; Dalgaard, LT; Hardikar, AA |
| 2021-01 | Studying the Oncosuppressive Functions of PTENP1 as a ceRNA. | Travis, G; Haddadi, N; Simpson, AM; Marsh, DJ; McGowan, EM; Nassif, NT |
| 2019-10-15 | Toward Systems Pathology for PTEN Diagnostics. | Haddadi, N; Travis, G; Nassif, NT; Simpson, AM; Marsh, DJ |
| 2019-01-01 | Ex vivo expansion of murine MSC impairs transcription factor-induced differentiation into pancreatic β-cells | Gerace, D; Martiniello-Wilks, R; Habib, R; Ren, B; Nassif, NT; O'Brien, BA; Simpson, AM |
| 2018-07-17 | Heart Rate Variability as a Biomarker for Predicting Stroke, Post-stroke Complications and Functionality | Lees, T; Shad-Kaneez, F; Simpson, AM; Nassif, NT; Lin, Y; Lal, S |
| 2018-05-01 | Partial pancreatic transdifferentiation of primary human hepatocytes in the livers of a humanised mouse model | Ren, B; La, QT; O'Brien, BA; Nassif, NT; Tan, Y; Gerace, D; Martiniello-Wilks, R; Torpy, F; Dane, AP; Alexander, IE; Simpson, AM |
| 2018-02-19 | PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy | Haddadi, N; Lin, Y; Travis, G; Simpson, AM; McGowan, EM; Nassif, NT |
| 2018-01-01 | EXPRESSION OF HUMAN PANCREATIC TRANSCRIPTION FACTORS IN THE LIVERS OF FRG MICE | Ren, B; La, QT; O'Brien, BA; Nassif, NT; Tan, Y; Gerace, D; Martiniello-Wilks, R; Torpy, F; Dane, AP; Alexander, IE; Simpson, AM |
| 2017-09-02 | “Dicing and splicing” sphingosine kinase and relevance to cancer | Haddadi, N; Lin, Y; Simpson, AM; Nassif, NT; McGowan, EM |
| 2017-06-01 | Ex Vivo Expanded Murine Mesenchymal Stem Cells as Targets for the Generation of a Cell Replacement Therapy for Type 1 Diabetes | Gerace, D; Martiniello-Wilks, R; Nassif, NT; Ren, B; Simpson, AM |
| 2017-03-09 | CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: A path to clinical success? | Gerace, D; Martiniello-Wilks, R; Nassif, NT; Lal, S; Steptoe, R; Simpson, AM |
| 2017-01-01 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: Challenges for SphK as an oncotarget | Hatoum, D; Haddadi, N; Lin, Y; Nassif, NT; McGowan, EM |
| 2017-01-01 | Annexin/S100A protein family regulation through p14ARF-p53 activation: A role in cell survival and predicting treatment outcomes in breast cancer | Hatoum, D; Yagoub, D; Ahadi, A; Nassif, NT; McGowan, EM |
| 2016-04-08 | Pancreatic transdifferentiation and glucose-regulated production of human insulin in the H4IIE rat liver cell line | Ren, B; Tao, C; Swan, MA; Joachim, N; Martiniello-Wilks, R; Nassif, NT; O’Brien, BA; Simpson, AM |
| 2015-11-01 | GENE THERAPY FOR DIABETES: REVERSAL OF DIABETES IN THE HUMANISED FRG MOUSE MODEL. | Simpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R |
| 2015-11-01 | Gene therapy for diabetes: reversal of diabetes in the humanised FRG mouse model | Simpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R |
